Back

Discussion.

29 August 2022 (13:32 - 13:45)
Organised by:
Congress Presentation Part of: SGLT-2 inhibitors - Another piece of the puzzle in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) Open Access ESC Congress 2022

5 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
SGLT2 inhibitors across the spectrum of heart failure.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
Practical considerations for treating HF with mildly reduced and preserved EF.
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Implementing best practices across the spectrum of heart failure.
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Summary.
Slides Video

Access the full session

Session thumbnail
SGLT-2 inhibitors - Another piece of the puzzle in heart failure
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 13:32 CET
You may be interested in
thumbnail
Congress Session
SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?
26 August 2022
thumbnail
Congress Session
How do SGLT2 inhibitors act in heart failure?
26 August 2022
thumbnail
Congress Session
State of the art: new treatments for heart failure
22 May 2023
thumbnail
Congress Session
When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
22 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources